Development of the AAV6-Based Vectors With Selective Tropism and High Transduction Efficiency of Human Cancer Cells

被引：0
|
作者：
Sayroo, Rana [1 ]
Yin, Zifei [1 ,2 ]
Nalasco, Diego [1 ]
Pandya, Munjal [1 ]
Ling, Chen [1 ]
Ling, Changquan [2 ]
Aslanidi, George [1 ]
机构：
[1] Univ Florida, Dept Pediat, Div Cellular & Mol Therapy, Gainesville, FL USA
[2] Univ Tradit Chinese Med, Mil Med Univ 2, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY | 2015年 / 23卷
关键词：
D O I：
10.1016/S1525-0016(16)33922-3
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
313
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells
    R Sayroo
    D Nolasco
    Z Yin
    Y Colon-Cortes
    M Pandya
    C Ling
    G Aslanidi
    Gene Therapy, 2016, 23 : 18 - 25
  • [2] Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells
    Sayroo, R.
    Nolasco, D.
    Yin, Z.
    Colon-Cortes, Y.
    Pandya, M.
    Ling, C.
    Aslanidi, G.
    GENE THERAPY, 2016, 23 (01) : 18 - 25
  • [3] Development of the novel AAV-based vectors with selective tropism to human cancer cells
    Sayroo, Rana
    Yin, Zifei
    Nolasco, Diego
    Pandya, Munjal
    Ling, Chen
    Aslanidi, George
    CANCER RESEARCH, 2015, 75
  • [4] Engineering AAV6-Based Vectors for Improved Ocular Transduction Following Intravitreal and Intracameral Injection
    Crosson, Sean M.
    Choudhury, Shreyasi
    Peterson, James
    Bennett, Antonette
    Fajardo, Diego
    Komaromy, Andras
    Agbandje-McKenna, Mavis
    Boye, Sanford L.
    Boye, Shannon E.
    MOLECULAR THERAPY, 2021, 29 (04) : 28 - 28
  • [5] Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
    Cheng, B.
    Ling, C.
    Dai, Y.
    Lu, Y.
    Glushakova, L. G.
    Gee, S. W. Y.
    McGoogan, K. E.
    Aslanidi, G. V.
    Park, M.
    Stacpoole, P. W.
    Siemann, D.
    Liu, C.
    Srivastava, A.
    Ling, C.
    GENE THERAPY, 2012, 19 (04) : 375 - 384
  • [6] Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
    B Cheng
    C Ling
    Y Dai
    Y Lu
    L G Glushakova
    S W Y Gee
    K E McGoogan
    G V Aslanidi
    M Park
    P W Stacpoole
    D Siemann
    C Liu
    A Srivastava
    C Ling
    Gene Therapy, 2012, 19 : 375 - 384
  • [7] Mechanism of Transduction of Human Hematopoietic Cells by Recombinant AAV6 Vectors
    Song, Liujiang
    Li, Baozheng
    Wang, Yuan
    Ma, Wenqin
    Aslanidi, George V.
    Ling, Chen
    Ling, Changquang
    Tan, Mengqun
    Srivastava, Arun
    MOLECULAR THERAPY, 2012, 20 : S229 - S230
  • [8] Reverse transduction can improve efficiency of AAV vectors in transduction-resistant cells
    Lee, Esther J.
    Robinson, Tawana M.
    Tabor, Jeffrey J.
    Mikos, Antonios G.
    Suh, Junghae
    BIOTECHNOLOGY AND BIOENGINEERING, 2018, 115 (12) : 3042 - 3049
  • [9] Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses
    Ling, Chen
    Li, Baozheng
    Ma, Wenqin
    Srivastava, Arun
    HUMAN GENE THERAPY METHODS, 2016, 27 (04) : 143 - 149
  • [10] Comparative Analysis of the Transduction Efficiency of Five AAV Serotypes and Lentiviral Vectors in Lung Cancer Cells
    Chen, Chiachen
    Akerstrom, Victoria
    Baus, James
    Lan, Michael S.
    Breslin, Mary B.
    MOLECULAR THERAPY, 2012, 20 : S97 - S97
12345